全文获取类型
收费全文 | 119245篇 |
免费 | 7228篇 |
国内免费 | 1609篇 |
专业分类
耳鼻咽喉 | 1583篇 |
儿科学 | 2973篇 |
妇产科学 | 4109篇 |
基础医学 | 18361篇 |
口腔科学 | 3612篇 |
临床医学 | 9337篇 |
内科学 | 21683篇 |
皮肤病学 | 2441篇 |
神经病学 | 8052篇 |
特种医学 | 4074篇 |
外国民族医学 | 3篇 |
外科学 | 16803篇 |
综合类 | 5371篇 |
一般理论 | 34篇 |
预防医学 | 8709篇 |
眼科学 | 2827篇 |
药学 | 10270篇 |
1篇 | |
中国医学 | 882篇 |
肿瘤学 | 6957篇 |
出版年
2021年 | 1011篇 |
2019年 | 1070篇 |
2018年 | 1637篇 |
2017年 | 1186篇 |
2016年 | 1209篇 |
2015年 | 1470篇 |
2014年 | 1923篇 |
2013年 | 2473篇 |
2012年 | 3579篇 |
2011年 | 3846篇 |
2010年 | 2315篇 |
2009年 | 2064篇 |
2008年 | 3416篇 |
2007年 | 3653篇 |
2006年 | 3631篇 |
2005年 | 3174篇 |
2004年 | 2991篇 |
2003年 | 2789篇 |
2002年 | 2647篇 |
2001年 | 6748篇 |
2000年 | 6941篇 |
1999年 | 5718篇 |
1998年 | 1845篇 |
1997年 | 1397篇 |
1996年 | 945篇 |
1995年 | 881篇 |
1992年 | 3733篇 |
1991年 | 3810篇 |
1990年 | 3550篇 |
1989年 | 3552篇 |
1988年 | 3434篇 |
1987年 | 3280篇 |
1986年 | 3091篇 |
1985年 | 2967篇 |
1984年 | 2048篇 |
1983年 | 1792篇 |
1982年 | 985篇 |
1979年 | 1909篇 |
1978年 | 1184篇 |
1977年 | 986篇 |
1976年 | 918篇 |
1975年 | 1191篇 |
1974年 | 1358篇 |
1973年 | 1413篇 |
1972年 | 1357篇 |
1971年 | 1247篇 |
1970年 | 1137篇 |
1969年 | 1121篇 |
1968年 | 1024篇 |
1967年 | 897篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
发作性睡病是致残性白天睡眠增多的最常见原因之一,其治疗旨在减少白天睡眠增多和猝倒,改善夜间睡眠紊乱、睡眠瘫痪及与睡眠有关的幻觉。2019年,组胺H3受体拮抗剂替洛利生(Pitolisant)和多巴胺及去甲肾上腺素再摄取抑制剂索利氨酯(Solriamfetol)分别在欧盟和美国上市,前者具有促醒和抗猝倒作用,后者也有促醒作用,且戒断症状和滥用的发生率更低。目前,控释型羟丁酸钠(FT218)、低钠型羟丁酸盐(JZP-258)、选择性去甲肾上腺素再摄取抑制剂(瑞波西汀,又称AXS-12)以及莫达非尼联合氟卡尼制剂(THN102)等药物仍在开发和测试中,均可作为治疗发作性睡病相关白天睡眠增多和猝倒的潜在药物。本文重点介绍这些最近研发的发作性睡病治疗药物。 相似文献
3.
4.
5.
We report a Chinese family with members affected by epidermolytic ichthyosis (EI), caused by KRT gene mutations. The proband was a 14‐year‐old boy who had simultaneous appearance of nephroblastoma and epidermolytic ichthyosis (EI). Both the patient and his mother exhibited the specific clinical and pathological manifestations of EI. We analysed all exons and flanking sequences of the KRT1 and KRT10 genes using PCR, and found that the proband and his mother had a G>C transition at nucleotide position 1432 in exon 7 of KRT1, resulting in an amino acid substitution of glutamate (GAA) to glutamine (CAA) at codon 478 (E478Q). The KRT10 gene had no mutations. 相似文献
6.
7.
Y.R. Song B. Wu Y.T. Yang J. Chen L.J. Zhang Z.W. Zhang H.Y. Shi C.L. Huang J.X. Pan P. Xie 《Brazilian journal of medical and biological research》2015,48(11):973-982
Bipolar disorder (BD) is a common psychiatric mood disorder affecting more than 1-2%
of the general population of different European countries. Unfortunately, there is no
objective laboratory-based test to aid BD diagnosis or monitor its progression, and
little is known about the molecular basis of BD. Here, we performed a comparative
proteomic study to identify differentially expressed plasma proteins in various BD
mood states (depressed BD, manic BD, and euthymic BD) relative to healthy controls. A
total of 10 euthymic BD, 20 depressed BD, 15 manic BD, and 20 demographically matched
healthy control subjects were recruited. Seven high-abundance proteins were
immunodepleted in plasma samples from the 4 experimental groups, which were then
subjected to proteome-wide expression profiling by two-dimensional electrophoresis
and matrix-assisted laser desorption/ionization-time-of-flight/time-of-flight tandem
mass spectrometry. Proteomic results were validated by immunoblotting and
bioinformatically analyzed using MetaCore. From a total of 32 proteins identified
with 1.5-fold changes in expression compared with healthy controls, 16 proteins were
perturbed in BD independent of mood state, while 16 proteins were specifically
associated with particular BD mood states. Two mood-independent differential
proteins, apolipoprotein (Apo) A1 and Apo L1, suggest that BD pathophysiology may be
associated with early perturbations in lipid metabolism. Moreover, down-regulation of
one mood-dependent protein, carbonic anhydrase 1 (CA-1), suggests it may be involved
in the pathophysiology of depressive episodes in BD. Thus, BD pathophysiology may be
associated with early perturbations in lipid metabolism that are independent of mood
state, while CA-1 may be involved in the pathophysiology of depressive episodes. 相似文献
8.
C.Z. Simonsen S. Schnenberger P.L. Hendn A.J. Yoo L. Uhlmann A. Rentzos J. Bsel J. Valentin M. Rasmussen 《AJNR. American journal of neuroradiology》2020,41(12):2298
BACKGROUND AND PURPOSE:Endovascular therapy for acute ischemic stroke is often performed with the patient under conscious sedation. Emergent conversion from conscious sedation to general anesthesia is sometimes necessary. The aim of this study was to assess the functional outcome in converted patients compared with patients who remained in conscious sedation and to identify predictors associated with the risk of conversion.MATERIALS AND METHODS:Data from 368 patients, included in 3 trials randomizing between conscious sedation and general anesthesia before endovascular therapy (SIESTA, ANSTROKE, and GOLIATH) constituted the study cohort. Twenty-one (11%) of 185 patients randomized to conscious sedation were emergently converted to general anesthesia.RESULTS:Absence of hyperlipidemia seemed to be the strongest predictor of conversion to general anesthesia, albeit a weak predictor (area under curve = 0.62). Sex, hypertension, diabetes, smoking status, atrial fibrillation, blood pressure, size of the infarct, and level and side of the occlusion were not significantly associated with conversion to general anesthesia. Neither age (mean age, 71.3 ± 13.8 years for conscious sedation versus 71.6 ± 12.3 years for converters, P = .58) nor severity of stroke (mean NIHSS score, 17 ± 4 versus 18 ± 4, respectively, P = .27) were significantly different between converters and those who tolerated conscious sedation. The converters had significantly worse outcome with a common odds ratio of 2.67 (P = .015) for a shift toward a higher mRS score compared with the patients remaining in the conscious sedation group.CONCLUSIONS:Patients undergoing conversion had significantly worse outcome compared with patients remaining in conscious sedation. No factor was identified that predicted conversion from conscious sedation to general anesthesia.Five studies published in 2015 proved the efficacy of endovascular therapy (EVT) for acute ischemic stroke caused by a large-vessel occlusion.1 However, numerous questions remain regarding how to best deliver this treatment, including evaluation of the optimal thrombectomy technique,2 the most effective method of patient triage,3 or whether EVT should be performed with the patient under either general anesthesia (GA) or conscious sedation (CS).Observational studies have suggested that EVT with the patient under CS is associated with better neurologic outcome and lower mortality compared with GA.4 However, 3 randomized trials reported similar outcomes between CS and GA.5-7 Proposed benefits of CS include stable hemodynamics, clinical monitoring, and a potentially shorter procedure. The disadvantages are an unprotected airway and patient movement, which sometimes may require emergent conversion to GA. Patients who need conversion might be sicker (larger strokes, more medical complications), but the conversion procedure itself may also have a potentially deleterious influence on outcome due to the emergent anesthetic induction, associated hypotension, and added time delay before reperfusion.Although most patients can be treated under the less complex CS, it is of interest to identify factors that can predict the risk of conversion and hence the requirement for GA. We undertook a detailed analysis of the patients who were converted from CS to GA in our individual patient data base from the 3 randomized trials to examine the outcome of the converted patients compared with patients who remained in CS. We also aimed to identify possible predictors associated with a need for GA with EVT. 相似文献
9.
10.
目的 分析社区"5+1"糖尿病分阶段达标管理对2型糖尿病患者生存质量的干预效果及其影响因素,为提高患者生存质量提供依据。方法 采用分层整群抽样的方法在山西省、江苏省和宁夏回族自治区选择12个社区卫生服务中心,分别作为干预组(管理方式:社区"5+1"糖尿病分阶段达标管理)、对照组[管理方式:依据《国家基本公共卫生服务规范(2011年版)》的相关要求],进行为期2年的随访观察。采用面对面问卷调查的方式,收集患者的人口学信息等基本信息;采用健康调查简表(SF-36)对患者在干预前后测量生存质量。采用SAS 9.4软件进行双重差分法以及多重线性回归模型分析。结果 基线时共纳入2 467名研究对象,终末时共1 924人接受了为期2年完整的随访管理。干预后,干预组、对照组患者生理健康维度(PCS)、心理健康维度(MCS)评分变化净差值分别为13.6分、29.8分。多重线性回归分析结果显示,影响患者PCS得分的主要因素有年龄、医保类型、基线PCS得分以及所在地区,影响患者MCS得分的主要因素有年龄、医保类型、基线MCS得分、是否合并高血压以及所在地区。结论 社区"5+1"糖尿病分阶段达标管理对2型糖尿病患者生存质量的干预效果较好。 相似文献